Related Experiment Video
Updated: Dec 10, 2025

07:47
Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
2.6K
Radiomics in Hepatocellular Carcinoma
1Department of Radiology, Turgut Ozal Medical Center, Inonu University School of Medicine, 244280, Malatya, Turkey. mdasagir2003@hotmail.com.
Journal of Gastrointestinal Cancer
|August 27, 2020
Summary
Radiomics, extracting imaging data for non-invasive predictions, shows promise for early hepatocellular carcinoma (HCC) diagnosis and treatment. Further research is needed to overcome current challenges and advance its clinical application.
Area of Science:
- Radiology
- Oncology
- Medical Imaging Analysis
Background:
- Radiomics is an emerging field using high-throughput imaging data for non-invasive clinical outcome prediction.
- It holds significant potential for developing biomarkers in diagnosis, prognosis, and treatment response.
- Standardization is lacking, but radiomics offers a promising future for cancer management.
Purpose of the Study:
- To provide an updated overview of radiomics principles for hepatocellular carcinoma (HCC).
- To discuss current challenges in radiomics application for HCC.
- To explore future advancements in radiomics for HCC.
Main Methods:
- Review of current radiomics principles and applications in medical imaging.
- Focus on the specific relevance and challenges of radiomics in HCC.
- Discussion of existing literature and future research directions.
Main Results:
- Radiomics enables the extraction of quantitative features from medical images.
- Application in HCC can aid in early diagnosis and treatment planning.
- The field is rapidly evolving with potential for improved patient outcomes.
Conclusions:
- Radiomics is a powerful, non-invasive tool with substantial potential for HCC management.
- Addressing current challenges is crucial for widespread clinical adoption.
- Future advancements promise to enhance diagnostic and prognostic capabilities for HCC.

